{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:09:58Z","timestamp":1787886598346,"version":"build-2784847793"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.semnephrol.2024.151501","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T13:19:20Z","timestamp":1712236760000},"page":"151501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pediatric Kidney Transplantation: Cancer and Cancer Risk"],"prefix":"10.1016","volume":"44","author":[{"given":"Kaitlyn E.","family":"Order","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Rodig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/TP.0000000000002726","article-title":"Growth patterns after kidney transplantation in European children over the past 25 years: an ESPN\/ERA-EDTA registry study","volume":"104","author":"Bonthuis","year":"2020","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151501_bib0002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1399-3046.2010.01359.x","article-title":"Cognitive improvement in children with CKD after transplant","volume":"14","author":"Icard","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0003","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.kint.2022.09.026","article-title":"Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease","volume":"103","author":"Guha","year":"2023","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0004","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/j.1600-6143.2008.02410.x","article-title":"Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation","volume":"8","author":"Gillen","year":"2008","journal-title":"Am J Transplant"},{"issue":"26","key":"10.1016\/j.semnephrol.2024.151501_bib0005","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa031643","article-title":"Long-term survival of children with end-stage renal disease","volume":"350","author":"McDonald","year":"2004","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.semnephrol.2024.151501_bib0006","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151501_bib0007","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1681\/ASN.2021071020","article-title":"Transplantation mediates much of the racial disparity in survival from childhood-onset kidney failure","volume":"33","author":"Becerra","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0008","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1681\/ASN.0000000000000118","article-title":"Life years lost in children with kidney failure: a binational cohort study with multistate probabilities of death and life expectancy","volume":"34","author":"Wyld","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0009","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2215\/CJN.07070619","article-title":"Survival after kidney transplantation during childhood and adolescence","volume":"15","author":"Francis","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2215\/CJN.14620920","article-title":"Managing patients with failing kidney allograft: many questions remain","volume":"17","author":"Davis","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0011","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/gfp497","article-title":"Malignancy incidence after renal transplantation in children: a 20-year single-centre experience","volume":"25","author":"Koukourgianni","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151501_bib0012","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1111\/ajt.14289","article-title":"Incidence and predictors of cancer following kidney transplantation in childhood","volume":"17","author":"Francis","year":"2017","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0013","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2215\/CJN.03630415","article-title":"Long-term risk of cancer in survivors of pediatric ESRD","volume":"10","author":"Ploos van Amstel","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0014","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ndt\/gfy210","article-title":"Medication adherence is associated with an increased risk of cancer in kidney transplant recipients: a cohort study","volume":"34","author":"Yadav","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0015","doi-asserted-by":"crossref","first-page":"e13597","DOI":"10.1111\/petr.13597","article-title":"Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS","volume":"23","author":"Chua","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0016","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/petr.12166","article-title":"Solid tumors following kidney transplantation in children","volume":"17","author":"Smith","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0017","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1097\/TXD.0000000000001137","article-title":"Cancer after pediatric kidney transplantation: a long-term single-center experience in Japan","volume":"7","author":"Yabuuchi","year":"2021","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0018","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post-organ transplant hematologic cancers","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0019","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2021.01.015","article-title":"Posttransplant lymphoproliferative disorder following kidney transplantation: a review","volume":"78","author":"Sprangers","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2 suppl 1","key":"10.1016\/j.semnephrol.2024.151501_bib0020","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 annual data report: kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0021","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfx356","article-title":"Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study","volume":"33","author":"Francis","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"2 suppl 1","key":"10.1016\/j.semnephrol.2024.151501_bib0022","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 annual data report: liver","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"issue":"2 suppl 1","key":"10.1016\/j.semnephrol.2024.151501_bib0023","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1016\/j.ajt.2023.02.008","article-title":"OPTN\/SRTR 2021 annual data report: heart","volume":"23","author":"Colvin","year":"2023","journal-title":"Am J Transplant"},{"issue":"2 suppl 1","key":"10.1016\/j.semnephrol.2024.151501_bib0024","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/j.ajt.2023.02.009","article-title":"OPTN\/SRTR 2021 annual data report: lung","volume":"23","author":"Valapour","year":"2023","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151501_bib0025","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.tp.0000265914.16491.7d","article-title":"Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients","volume":"83","author":"Smith","year":"2007","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0026","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151501_bib0027","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","article-title":"Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study","volume":"56","author":"Hocker","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0029","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/tri.13079","article-title":"Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice","volume":"31","author":"Dharnidharka","year":"2018","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0030","doi-asserted-by":"crossref","first-page":"e13925","DOI":"10.1111\/petr.13925","article-title":"Primary pediatric live-donor-kidney transplant-recipients\u2019 outcomes by immunosuppression induction received in the United States","volume":"25","author":"Riad","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0031","doi-asserted-by":"crossref","first-page":"e13928","DOI":"10.1111\/petr.13928","article-title":"Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States","volume":"25","author":"Riad","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151501_bib0032","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s00467-023-05955-5","article-title":"Outcomes based on induction regimens in pediatric kidney transplantation: a NAPRTCS and PHIS collaborative study","volume":"38","author":"Erez","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151501_bib0033","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0034","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0b013e3181e46a22","article-title":"Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report","volume":"90","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0036","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/TP.0b013e3181c69855","article-title":"Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation","volume":"89","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0037","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151501_bib0038","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":"Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2024.151501_bib0039","series-title":"Challenges in Pediatric Kidney Transplantation: A Practical Guide","first-page":"145","article-title":"Post-transplant recipient infectious challenges","author":"Ashoor","year":"2021"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0041","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","article-title":"Characteristics of early and late PTLD development in pediatric solid organ transplant recipients","volume":"95","author":"Schober","year":"2013","journal-title":"Transplantation"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2024.151501_bib0042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hon.3139","article-title":"Post-transplant lymphoproliferative disease in children, adolescents, and young adults","volume":"41","author":"Gross","year":"2023","journal-title":"Hematol Oncol"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0043","first-page":"661","article-title":"Current practices on diagnosis, prevention and treatment of post-transplant lymphoproliferative disorder in pediatric patients after solid organ transplantation: results of ERN TransplantChild Healthcare Working Group survey","volume":"8","author":"Baker","year":"2021","journal-title":"Children (Basel)"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0044","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11899-021-00606-8","article-title":"Joining efforts for PTLD: lessons learned from comparing the approach and treatment strategies across the pediatric and adult age spectra","volume":"16","author":"Montanari","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"issue":"20","key":"10.1016\/j.semnephrol.2024.151501_bib0045","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0046","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0047","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181761659","article-title":"Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder","volume":"86","author":"Swinnen","year":"2008","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0048","doi-asserted-by":"crossref","first-page":"e14268","DOI":"10.1111\/petr.14268","article-title":"Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center","volume":"26","author":"Ramos-Gonzalez","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0049","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(\u2605)","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1600-6143.2011.03470.x","article-title":"Improved survival with recent post-transplant lymphoproliferative disorder (PTLD) in children with kidney transplants","volume":"11","author":"Dharnidharka","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0051","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/tri.13071","article-title":"Graft outcomes following diagnosis of post-transplant lymphoproliferative disease in pediatric kidney recipients: a retrospective study","volume":"31","author":"Kanzelmeyer","year":"2018","journal-title":"Transpl Int"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151501_bib0052","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3324\/haematol.11360","article-title":"Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease","volume":"92","author":"Gonzalez-Barca","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0053","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","article-title":"Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial","volume":"35","author":"Trappe","year":"2017","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.semnephrol.2024.151501_bib0054","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","article-title":"Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation","volume":"23","author":"Gross","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151501_bib0055","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","article-title":"Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group report","volume":"12","author":"Gross","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0056","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/tri.14107","article-title":"EBV-specific cytotoxic T lymphocytes for refractory EBV-associated post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review","volume":"34","author":"Liu","year":"2021","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0057","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13133","article-title":"Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children","volume":"22","author":"Chiou","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.semnephrol.2024.151501_bib0058","doi-asserted-by":"crossref","DOI":"10.1177\/0963689721996649","article-title":"Successful treatment of pediatric refractory Burkitt lymphoma PTLD after liver transplantation using anti-CD19 chimeric antigen receptor T-cell therapy","volume":"30","author":"Wang","year":"2021","journal-title":"Cell Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0059","doi-asserted-by":"crossref","first-page":"e13302","DOI":"10.1111\/petr.13302","article-title":"Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder","volume":"22","author":"Kassa","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151501_bib0060","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/ajt.15811","article-title":"Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: a systematic review","volume":"20","author":"d'Izarny-Gargas","year":"2020","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0061","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2010.08448.x","article-title":"CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation","volume":"152","author":"Orjuela","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0062","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.34600","article-title":"Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders","volume":"129","author":"Afify","year":"2023","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151501_bib0063","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/ajt.15358","article-title":"Posttransplant lymphoproliferative disorder in pediatric patients: survival rates according to primary sites of occurrence and a proposed clinical categorization","volume":"19","author":"L'Huillier","year":"2019","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"10.1016\/j.semnephrol.2024.151501_bib0064","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14471","article-title":"The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: III\u2014consensus guidelines for Epstein-Barr virus load and other biomarker monitoring","volume":"28","author":"Preiksaitis","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0066","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-017-3627-2","article-title":"Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients","volume":"32","author":"Colombini","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0067","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0068","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41390-019-0591-5","article-title":"The promise of a prophylactic Epstein-Barr virus vaccine","volume":"87","author":"Balfour","year":"2020","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0069","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamadermatol.2017.0045","article-title":"Comparison of posttransplant dermatologic diseases by race","volume":"153","author":"Chung","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"17","key":"10.1016\/j.semnephrol.2024.151501_bib0070","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151501_bib0071","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","article-title":"Skin cancer in organ transplant recipients\u2014where do we stand today?","volume":"8","author":"Ulrich","year":"2008","journal-title":"Am J Transplant"},{"issue":"4 Pt 2","key":"10.1016\/j.semnephrol.2024.151501_bib0072","first-page":"616","article-title":"Skin cancers following pediatric organ transplantation","volume":"30","author":"Euvrard","year":"2004","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0073","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/adc.85.6.478","article-title":"De novo malignancy after paediatric renal replacement therapy","volume":"85","author":"Coutinho","year":"2001","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0074","first-page":"56","article-title":"De novo malignances in pediatric organ transplant recipients","volume":"2","author":"Penn","year":"1998","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0075","doi-asserted-by":"crossref","first-page":"e14146","DOI":"10.1111\/petr.14146","article-title":"Outcomes of skin cancers in pediatric solid organ transplant patients: a systematic review","volume":"26","author":"Sachdeva","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0076","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2133.2006.07546.x","article-title":"Skin surveillance of a U.K. paediatric transplant population","volume":"156","author":"Thomson","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0077","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/bjd.16697","article-title":"A 10-year longitudinal follow-up study of a U.K. paediatric transplant population to assess for skin cancer","volume":"179","author":"Foo","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0078","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jamadermatol.2016.3328","article-title":"Nonmelanoma skin cancer in nonwhite organ transplant recipients","volume":"152","author":"Pritchett","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0079","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12659\/AOT.881994","article-title":"Skin cancer after renal transplantation: results of a multicenter study in Iran","volume":"15","author":"Einollahi","year":"2010","journal-title":"Ann Transplant"},{"issue":"5742","key":"10.1016\/j.semnephrol.2024.151501_bib0080","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"O'Donovan","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0081","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0082","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0083","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0084","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2015.05.029","article-title":"Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)","volume":"73","author":"Asgari","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2012.11213.x","article-title":"Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients","volume":"168","author":"Mihalis","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0086","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0087","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151501_bib0088","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.14382","article-title":"Skin cancers in organ transplant recipients","volume":"17","author":"Mittal","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0089","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ajt.14966","article-title":"Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.semnephrol.2024.151501_bib0090","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ejca.2006.05.010","article-title":"Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Pastore","year":"2006","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151501_bib0091","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/cncr.20548","article-title":"Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma","volume":"101","author":"Geller","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0092","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/cncr.22346","article-title":"Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts","volume":"107","author":"Selle","year":"2006","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151501_bib0093","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/ijc.33147","article-title":"Incidence of childhood renal tumours: an international population-based study","volume":"147","author":"Nakata","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0094","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/TP.0000000000003762","article-title":"Renal cell carcinoma and kidney transplantation: a narrative review","volume":"106","author":"Dahle","year":"2022","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0095","doi-asserted-by":"crossref","first-page":"e13614","DOI":"10.1111\/petr.13614","article-title":"Allograft renal cell carcinoma in pediatrics transplantation: a mini-review","volume":"24","author":"Geramizadeh","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0096","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/1744-9987.12509","article-title":"Differences in clinical and pathological features of renal cell carcinoma between Japanese patients after kidney transplantation and those on hemodialysis","volume":"21","author":"Takagi","year":"2017","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2024.151501_bib0097","article-title":"Treatment of allograft renal cell carcinoma with partial nephrectomy in a pediatric kidney transplant","volume":"73","author":"Tabbara","year":"2021","journal-title":"J Pediatr Surg Case Rep"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0098","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1055\/s-0042-1759546","article-title":"Bilateral native kidney papillary renal cell carcinomas in a 11-year-old renal transplant patient","volume":"10","author":"Durakbasa","year":"2022","journal-title":"European J Pediatr Surg Rep"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0099","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0391560319887323","article-title":"Bilateral renal cell carcinoma of the native kidneys in a 16-year-old boy: report of a rare case and review of the literature","volume":"87","author":"Geramizadeh","year":"2020","journal-title":"Urologia"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00858138","article-title":"Renal cell carcinoma developing in the pediatric recipient of an adult cadaveric donor kidney","volume":"8","author":"Agrawal","year":"1994","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0101","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0272-6386(95)90063-2","article-title":"Metastatic renal carcinoma in a pediatric recipient of an adult cadaveric donor kidney","volume":"26","author":"Lotan","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"11-12","key":"10.1016\/j.semnephrol.2024.151501_bib0102","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1159\/000509292","article-title":"Nephron sparing surgery in renal allograft in recipients with de novo renal cell carcinoma: two case reports and review of the literature","volume":"104","author":"Hubatsch","year":"2020","journal-title":"Urol Int"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151501_bib0103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jmg.2006.041723","article-title":"Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour","volume":"43","author":"Scott","year":"2006","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mpo.2950210305","article-title":"Epidemiology of Wilms tumor","volume":"21","author":"Breslow","year":"1993","journal-title":"Med Pediatr Oncol"},{"issue":"13","key":"10.1016\/j.semnephrol.2024.151501_bib0105","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.34219","article-title":"Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: a prospective study (COG AREN0534)","volume":"128","author":"Chintagumpala","year":"2022","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0106","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/SLA.0000000000002356","article-title":"Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children's Oncology Group","volume":"266","author":"Ehrlich","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.semnephrol.2024.151501_bib0107","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1120797","article-title":"Ex vivo tumor dissection followed by kidney autotransplantation in bilateral Wilms tumor","volume":"11","author":"Zhong","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.semnephrol.2024.151501_bib0108","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.1047975","article-title":"Bench surgery with autotransplantation for bilateral Wilms tumor\u2014a feasible technique for renal sinus invasion","volume":"9","author":"Gao","year":"2022","journal-title":"Front Surg"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0109","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1097\/01.ju.0000176800.00994.3a","article-title":"End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System","volume":"174","author":"Breslow","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151501_bib0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.juro.2011.03.110","article-title":"Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor","volume":"186","author":"Lange","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151501_bib0111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-3046.2005.00311.x","article-title":"Outcome of renal transplantation for Wilms\u2019 tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study","volume":"9","author":"Kist-van Holthe","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0112","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-5347(17)56607-0","article-title":"Renal transplantation for Wilms tumor: report of 20 cases","volume":"122","author":"Penn","year":"1979","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151501_bib0113","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00467-012-2140-x","article-title":"Treatments and outcomes for end-stage renal disease following Wilms tumor","volume":"27","author":"Grigoriev","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"suppl 16","key":"10.1016\/j.semnephrol.2024.151501_bib0114","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1681\/ASN.V11suppl_2s106","article-title":"Wilms\u2019 tumor suppressor gene WT1: from structure to renal pathophysiologic features","volume":"11","author":"Mrowka","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1542\/peds.2004-0467","article-title":"WAGR syndrome: a clinical review of 54 cases","volume":"116","author":"Fischbach","year":"2005","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151501_bib0116","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00467-006-0208-1","article-title":"WT1 and glomerular diseases","volume":"21","author":"Niaudet","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151501_bib0117","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ckj\/sfz022","article-title":"Long-term outcome in a case series of Denys-Drash syndrome","volume":"12","author":"Roca","year":"2019","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0118","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.10141014","article-title":"Clinical and molecular characterization of patients with heterozygous mutations in Wilms tumor suppressor gene 1","volume":"10","author":"Lehnhardt","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151501_bib0119","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ki.2013.519","article-title":"Genotype-phenotype associations in WT1 glomerulopathy","volume":"85","author":"Lipska","year":"2014","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.semnephrol.2024.151501_bib0120","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0121","doi-asserted-by":"crossref","first-page":"16025","DOI":"10.1038\/s41598-020-71956-1","article-title":"Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)","volume":"10","author":"Burgmaier","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151501_bib0122","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1940-6207.CAPR-14-0415","article-title":"Gonadal tumor in Frasier syndrome: a review and classification","volume":"8","author":"Ezaki","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151501_bib0123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pbc.21759","article-title":"Management of Wilms tumors in Drash and Frasier syndromes","volume":"52","author":"Auber","year":"2009","journal-title":"Pediatr Blood Cancer"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:51:54Z","timestamp":1748357514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929524000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0270929524000184"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151501","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Kidney Transplantation: Cancer and Cancer Risk","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151501"}}